search
Back to results

Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Patients Undergoing Total Thyroidectomy. (BSCPB_Block)

Primary Purpose

Analgesia Obtained With a Local Wound Infiltration of Lidocain, Analgesia Obtained With a Ultrasound Guided Cervical Plexus Block Using Lidocain, Postoperative Pain

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Block type
Sponsored by
University Hospital, Linkoeping
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Analgesia Obtained With a Local Wound Infiltration of Lidocain

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

ASA I-II, and were scheduled for total thyroidectomy

-

Exclusion Criteria:

documented allergy to study's intervention, moderate-to-severe obesity, > 1st-degree heart block, chronic pulmonary or cardiac diseases, hepatic or renal dysfunction, and/or coagulopathies.

All patients were required to fill the informed consent before enrollment.

Sites / Locations

  • Linköping University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

bilateral superficial cervical plexus block (BSCPB)

local wound infiltration (LWI)

Arm Description

Analgesia obtained by a ultrasound guided cervical plexus block using lidocain

Analgesia obtained by local wound infiltration of lidocain

Outcomes

Primary Outcome Measures

postoperative opioid consumption in the first postoperative day
postoperative opioid consumption in the first postoperative day in milligrams

Secondary Outcome Measures

total intraoperative fentanyl (mg) and isoflurane consumption (ml)
total intraoperative fentanyl and isoflurane consumption in micrograms and ml
time to first required analgesic
time to first required analgesic
VAS (10 cm; range): Pain average (VAS) for the first 24 hours postoperatively
VAS (10 cm; range) Pain average (VAS) for the first 24 hours postoperatively

Full Information

First Posted
June 10, 2021
Last Updated
July 28, 2021
Sponsor
University Hospital, Linkoeping
Collaborators
Ahmed Mohamed Abdelrahman, Mahmoud Ahmed Mewafy, Abdelrhman Alshawadfy, Haidi Abd-Elzaher, Hamada Fathy, Mohamed Faisal
search

1. Study Identification

Unique Protocol Identification Number
NCT04993521
Brief Title
Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Patients Undergoing Total Thyroidectomy.
Acronym
BSCPB_Block
Official Title
Ultrasound Guided Bilateral Superficial Cervical Plexus Block Versus Local Wound Infiltration in Patients Undergoing Total Thyroidectomy: A Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
January 31, 2021 (Actual)
Study Completion Date
May 15, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Linkoeping
Collaborators
Ahmed Mohamed Abdelrahman, Mahmoud Ahmed Mewafy, Abdelrhman Alshawadfy, Haidi Abd-Elzaher, Hamada Fathy, Mohamed Faisal

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The present study compared the efficacy of bilateral superficial cervical plexus block (BSCPB) versus local wound infiltration (LWI) regarding the postoperative opioid consumption in patients undergoing total thyroidectomy
Detailed Description
We performed a double-blind, randomised, controlled trial that recruited patients undergoing total thyroidectomy at the Suez Canal University Hospital during the period between February 2019 and January 2021. Patients were eligible if they were older than 20 years, had an American Association of Anesthesiologists' (ASA) level of I-II, and were scheduled for total thyroidectomy. We excluded patients with documented allergies to the study's intervention materials, moderate-to-severe obesity, > 1st-degree heart block, chronic pulmonary or cardiac diseases, hepatic or renal dysfunction, and/or coagulopathies. All patients were required to fill out informed consent before enrollment. Eligible patients were randomly allocated in a 1:1 ratio to receive BSCPB or LWI using the computer software program (www. Randmizer.org) and allocation sequences were done using opaque, closed envelopes. The BSCPB group received BSCBP (after general anaesthesia but before the start of surgery) from two syringes containing ropivacaine 0.5 % and LWI with saline. The LWI group received LWI with ropivacaine 0.5% and the BSCPB from two syringes containing saline. The primary outcome of the present study was postoperative opioid consumption in the first postoperative day. The secondary outcomes included the total intraoperative fentanyl and isoflurane consumption, time to first required analgesic, and VAS during the first 24 hours postoperatively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Analgesia Obtained With a Local Wound Infiltration of Lidocain, Analgesia Obtained With a Ultrasound Guided Cervical Plexus Block Using Lidocain, Postoperative Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A Randomized Controlled Study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
bilateral superficial cervical plexus block (BSCPB)
Arm Type
Active Comparator
Arm Description
Analgesia obtained by a ultrasound guided cervical plexus block using lidocain
Arm Title
local wound infiltration (LWI)
Arm Type
Active Comparator
Arm Description
Analgesia obtained by local wound infiltration of lidocain
Intervention Type
Procedure
Intervention Name(s)
Block type
Other Intervention Name(s)
Ultrasound guided bilateral superficial cervical plexus nerve block
Intervention Description
Regular block type
Primary Outcome Measure Information:
Title
postoperative opioid consumption in the first postoperative day
Description
postoperative opioid consumption in the first postoperative day in milligrams
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
total intraoperative fentanyl (mg) and isoflurane consumption (ml)
Description
total intraoperative fentanyl and isoflurane consumption in micrograms and ml
Time Frame
6 hours
Title
time to first required analgesic
Description
time to first required analgesic
Time Frame
6 hours
Title
VAS (10 cm; range): Pain average (VAS) for the first 24 hours postoperatively
Description
VAS (10 cm; range) Pain average (VAS) for the first 24 hours postoperatively
Time Frame
every 6 hours until 24 hours postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA I-II, and were scheduled for total thyroidectomy - Exclusion Criteria: documented allergy to study's intervention, moderate-to-severe obesity, > 1st-degree heart block, chronic pulmonary or cardiac diseases, hepatic or renal dysfunction, and/or coagulopathies. All patients were required to fill the informed consent before enrollment.
Facility Information:
Facility Name
Linköping University Hospital
City
Linköping
ZIP/Postal Code
58185
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Can be shared on reasonable terms

Learn more about this trial

Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Patients Undergoing Total Thyroidectomy.

We'll reach out to this number within 24 hrs